Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 10/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 3/20 | 0.36 |
| ▸ | MMP14 | P50281 | 2/20 | 0.36 |
| ▸ | ADAMTS5 | Q9UNA0 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | F13A1 | P00488 | 1/20 | 0.35 |
| ▸ | TGM2 | P21980 | 1/20 | 0.35 |
| ▸ | TGM1 | P22735 | 1/20 | 0.35 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2503392 | 0.92 | GPR119 (0.37) | GPR119DPP4MMP13MMP14ADAMTS5 | |
| SCHEMBL2480116 | 0.90 | ALDH1A1 (0.37) | GPR119DPP4SMN1; SMN2MEN1CYP2C19 | |
| SCHEMBL2452755 | 0.89 | MAOA (0.40) | GPR119DPP4MMP13MMP14ADAMTS5 | |
| SCHEMBL2480377 | 0.85 | GPR119 (0.40) | GPR119DPP4MMP13MMP14ADAMTS5 | |
| SCHEMBL2486341 | 0.84 | MAOB (0.45) | GPR119 | |
| SCHEMBL2507043 | 0.84 | GPR119 (0.41) | GPR119DPP4MMP13MMP14ADAMTS5 | |
| SCHEMBL2504492 | 0.82 | KDM4E (0.37) | GPR119F13A1TGM2TGM1 | |
| SCHEMBL2499942 | 0.80 | GPR119 (0.39) | GPR119F13A1TGM2TGM1SCN9A | |
| SCHEMBL2480117 | 0.80 | MEN1 (0.41) | MMP13MMP14ADAMTS5ADAM17MEN1 | |
| SCHEMBL2498576 | 0.80 | HPGD (0.39) | GPR119DPP4SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8841306-B2 | Antimicrobials | PANACEA BIOTEC LTD. (IN) | 2014-09-23 | — | — | US | disclosed |
| US-20110245258-A1 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LTD. (IN) | 2011-10-06 | — | — | US | disclosed |
| EP-2367820-A2 | Novel antimicrobials | Panacea Biotec Limited (IN) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010058423-A2 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LTD. (IN) | 2010-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245258-A1 | NOVEL ANTIMICROBIALS | ECI1, XDH, CYP3A4 | GPR119 2490/4885DPP4 436/4885MMP13 2704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.